Immunotherapy May Treat This Deadly Breast Cancer – TIME
TIME |
Immunotherapy May Treat This Deadly Breast Cancer
TIME But in a new presentation at the annual American Association for Cancer Research meeting, researchers say that one of the latest immunotherapy drugs called atezolizumab, or Tecentriq, may help people with triple negative breast cancer to live longer. First Survival Results With Immunotherapy, TNBC Breast Cancer 'Immunotherapy' Helps Some With Tough-to-Treat Disease Triple-negative Breast Cancer Patients Who Responded to Immunotherapy Had Long-term Survival Benefit |
